Leerink Reiterates Outperform Rating on Nuvalent (NUVL)

June 3, 2026 6:19 AM

Leerink analyst Andrew Berens reiterated an Outperform rating and $165.00 price target on Nuvalent (NASDAQ: NUVL).The analyst comments "We spoke ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found